Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency

BACKGROUND: TV-1106 (Teva Pharmaceuticals) is a genetically fused recombinant protein of human GH (hGH) and human serum albumin, in development for treatment of GH deficiency (GHD). TV-1106 is expected to have an extended duration of action compared to daily GH treatment and may enable a reduction i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen-Barak, Orit, Sakov, Anat, Rasamoelisolo, Michele, Bassan, Merav, Brown, Kurt, Mendzelevski, Boaz, Spiegelstein, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584421/
https://www.ncbi.nlm.nih.gov/pubmed/26286586
http://dx.doi.org/10.1530/EJE-15-0554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584421/
https://www.ncbi.nlm.nih.gov/pubmed/26286586
http://dx.doi.org/10.1530/EJE-15-0554

Ejemplares similares